Inovio Pharmaceuticals Aktie
WKN DE: A115GK / ISIN: US45773H2013
03.07.2025 04:31:08
|
INOVIO Pharma Announces Proposed Public Offering
(RTTNews) - INOVIO Pharmaceuticals Inc. (INO) announced that it intends to offer and sell shares of its common stock (or pre-funded warrants to purchase its common stock in lieu thereof) and in either case, accompanying Series A warrants and Series B warrants to purchase shares of its common stock (or pre-funded warrants to purchase its common stock in lieu thereof), in an underwritten public offering.
INOVIO said it plans to grant the underwriter a 30-day option to purchase additional shares of its common stock and/or accompanying Series A and Series B warrants to purchase shares of its common stock in an amount up to 15% of the securities offered in the public offering under the same terms and conditions.
Piper Sandler & Co. is acting as sole book-running manager for the offering.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Inovio Pharmaceuticals Incmehr Nachrichten
Keine Nachrichten verfügbar. |